Literature DB >> 17457812

STAT3: a critical transcription activator in angiogenesis.

Zhong Chen1, Zhong Chao Han.   

Abstract

Angiogenesis, the formation of new blood vessels from the pre-existing vasculature, is a complex multistage process regulated by a number of signal transduction pathways. Accumulating evidence suggests that signal transducer and activator of transcription (STATs), mainly STAT3, play an important role in angiogenesis under both physiological and pathological conditions in addition to cell survival, proliferation, differentiation, and oncogenesis. STAT3, as a critical multifunctional mediator, regulates many aspects of angiogenesis at the transcriptional level. This review will highlight the pivotal role of STAT3 in well-studied tumorous angiogenesis and cardiac angiogenesis, and summarize various potential mechanisms utilized by STAT3 to regulate the transcriptional activation of VEGF. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17457812     DOI: 10.1002/med.20101

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  115 in total

1.  (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

Authors:  Bao-He Zhu; Hua-Yun Chen; Wen-Hua Zhan; Cheng-You Wang; Shi-Rong Cai; Zhao Wang; Chang-Hua Zhang; Yu-Long He
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Loss of interleukin-21 receptor activation in hypoxic endothelial cells impairs perfusion recovery after hindlimb ischemia.

Authors:  Tao Wang; Alexis Cunningham; Ayotunde O Dokun; Surovi Hazarika; Kevin Houston; Lingdan Chen; R John Lye; Rosanne Spolski; Warren J Leonard; Brian H Annex
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

3.  Inflammatory cytokine-specific alterations in retinal endothelial cell function.

Authors:  Tammy L Palenski; Christine M Sorenson; Nader Sheibani
Journal:  Microvasc Res       Date:  2013-06-24       Impact factor: 3.514

4.  Expression of STAT3 and IGF2 in adrenocortical carcinoma and its relationship with angiogenesis.

Authors:  Y Zhu; Y Xu; D Chen; C Zhang; W Rui; J Zhao; Q Zhu; Y Wu; Z Shen; W Wang; G Ning; X Wang
Journal:  Clin Transl Oncol       Date:  2013-11-01       Impact factor: 3.405

5.  Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms.

Authors:  Farah Kako; Khatuna Gabunia; Mitali Ray; Sheri E Kelemen; Ross N England; Bashar Kako; Rosario G Scalia; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

6.  Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

Authors:  Junhua Mai; Yi Huang; Chaofeng Mu; Guodong Zhang; Rong Xu; Xiaojing Guo; Xiaojun Xia; David E Volk; Ganesh L Lokesh; Varatharasa Thiviyanathan; David G Gorenstein; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

7.  Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity.

Authors:  Xiao-Wen Zhu; Hai-Zhen Zhu; You-Qing Zhu; Mao-Hui Feng; Jian Qi; Zhi-Fen Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

8.  Anti-angiogenic effect of total saponins of Rhizoma Dioscorea nipponica on collagen induced-arthritis in rats.

Authors:  Xiu-Jun Liang; Ya-Chun Guo; Tong-You Sun; Hong-Ru Song; Ya-Xian Gao
Journal:  Exp Ther Med       Date:  2016-08-10       Impact factor: 2.447

9.  Effects of general anesthesia with or without epidural block on tumor metastasis and mechanisms.

Authors:  Bin Yang; Feng Qian; Wenjia Li; Yang Li; Yangdong Han
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

10.  STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.

Authors:  Guo-Shi Lin; Li-Juan Yang; Xing-Fu Wang; Yu-Peng Chen; Wen-Long Tang; Long Chen; Zhi-Xiong Lin
Journal:  Med Oncol       Date:  2014-03-21       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.